{
  "docId": "019de072-9664-765c-aed1-7258b79177ce",
  "docSlug": "6ed2ec9316cb33af47e796240bef9e8e",
  "documentTitle": "AbCellera | Results Presentation Deck | 14 slides",
  "authorId": "abcellera",
  "authorName": "AbCellera",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-05-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 6,
  "pageCount": 14,
  "prevPage": 5,
  "nextPage": 7,
  "slideType": "thesis_headline",
  "function": "present_solution",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": "The visual shows a bispecific antibody structure connecting CD3-binding and tumor-binding arms.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de072-9664-765c-aed1-7258b79177ce/6",
  "deckHref": "/decks/019de072-9664-765c-aed1-7258b79177ce",
  "deckJsonHref": "/decks/019de072-9664-765c-aed1-7258b79177ce.json",
  "deckAnchorHref": "/decks/019de072-9664-765c-aed1-7258b79177ce#slide-6",
  "components": [
    {
      "bbox": {
        "h": 0.5,
        "w": 0.5,
        "x": 0.45,
        "y": 0.25
      },
      "kind": "image",
      "text": "Visual representation of bispecific antibody structure",
      "attrs": null,
      "subkind": "illustration",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ad55cbf0-79ec-4c20-b5fc-b8b0cf3981ba",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.45,
        "x": 0.48,
        "y": 0.83
      },
      "kind": "list",
      "text": "Diverse, Developable, Validated",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "35314c1b-7293-41d0-b613-4b37c5c5010d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.4,
        "x": 0.08,
        "y": 0.54
      },
      "kind": "paragraph",
      "text": "We used our technology to find hundreds of CD3-binding antibodies that can be combined to create precision cancer therapies. We then used our clinically-validated bispecifics platform, OrthoMab™ to pair the CD3-binding antibodies with a single EGFR-binding arm and confirm their function.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6d0b2285-8b18-4695-9cf8-86055d8ac7e2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.4,
        "x": 0.08,
        "y": 0.21
      },
      "kind": "title",
      "text": "A DIVERSE PANEL OF CD3 ANTIBODIES TO CREATE NEW CANCER THERAPIES",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0a6be288-f0ba-4118-8df2-5b9b6199e0b2",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 10,
      "from": 6,
      "beatId": "e931b600-6750-4721-9374-f8e99d32ee89",
      "arcName": "Monroe's Motivated Sequence",
      "arcSlug": "monroes-sequence",
      "beatName": "Satisfaction",
      "beatSlug": "monroes-sequence-satisfaction",
      "evidence": "The presentation provides an update on the company's financial performance and portfolio growth",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    }
  ],
  "loops": [
    {
      "to": 10,
      "from": 3,
      "name": "Logic Chain",
      "slug": "01-logic-chain",
      "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis",
      "matchId": "4575b066-2b5b-4477-b7aa-44021f2b6cb6",
      "evidence": "The presentation provides a clear logic chain from strong results to diversified capabilities",
      "position": 0,
      "objective": "To demonstrate the company's strong results and capabilities",
      "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)",
      "confidence": 0.7,
      "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}